Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InspireMD ( (NSPR) ) just unveiled an update.
On July 30, 2025, InspireMD entered into a securities purchase agreement for a private placement offering, raising approximately $40.1 million through the sale of common stock and pre-funded warrants. The offering is expected to close by August 1, 2025, and includes a registration rights agreement to file a resale registration statement with the SEC. Additionally, InspireMD announced the full exercise of its Series I warrants, generating $17.9 million in gross proceeds, and the combined financings of $58 million will bolster the company’s balance sheet to commercialize its FDA-approved CGuard Prime carotid stent in the U.S. market. The company aims to use the proceeds for operations, including sales, marketing, and research and development, positioning itself as a leader in the carotid intervention market.
The most recent analyst rating on (NSPR) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on InspireMD stock, see the NSPR Stock Forecast page.
Spark’s Take on NSPR Stock
According to Spark, TipRanks’ AI Analyst, NSPR is a Neutral.
InspireMD’s stock score reflects significant financial and valuation challenges, offset by positive corporate events and cautious optimism from recent earnings. The financial performance issues are the primary detractor, while recent regulatory approvals and market expansion plans offer potential upside.
To see Spark’s full report on NSPR stock, click here.
More about InspireMD
InspireMD, Inc. is a developer of the CGuard® Prime carotid stent system, which aims to prevent strokes. The company utilizes its proprietary MicroNet™ mesh technology to establish its products as the industry standard for carotid stenting, providing excellent acute results and long-term stroke-free outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.
Average Trading Volume: 153,484
Technical Sentiment Signal: Strong Sell
Current Market Cap: $74.75M
For detailed information about NSPR stock, go to TipRanks’ Stock Analysis page.